Literature DB >> 19013586

Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not?

Daniel J Costello1, Ronan D Kilbride, Andrew J Cole.   

Abstract

INTRODUCTION: In the majority of cases of New Onset Refractory Status Epilepticus (NORSE) in adults, a cause is discovered. However, some cases of NORSE remain undiagnosed, i.e. cryptogenic. They are usually presumed to be due to infectious encephalitis and typically have devastating consequences. We describe our experience with six adults who presented with NORSE and raise the possibility of non-infectious causes.
METHODS: Retrospective case series from an epilepsy service in a tertiary care urban hospital. We compare the clinical features of these cases with patients who develop NORSE in the setting of clinically-defined encephalitis from the California Encephalitis Project (most of whom are etiologically cryptogenic) as well as with patients who develop NORSE in the setting of proven infectious encephalitis.
RESULTS: We describe 6 previously-normal adults with NORSE where a cause was not established despite an exhaustive search. With an average duration of 36 days (range 6-68), the in-hospital and long-term morbidities were high; one patient died of the propofol infusion syndrome. In contradistinction to NORSE in the setting of etiologically-proven infectious encephalitis, these patients were afebrile and the abnormalities evident during their evaluation could be attributed to the ictal activity itself. Neuropathological examination revealed non-specific findings in 4 patients.
CONCLUSIONS: Though an underlying etiology remains unproven in these patients, we contend that NORSE is etiologically heterogeneous, with a proportion of cases due to non-infectious causes. Further study of this poorly understood form of status epilepticus is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013586     DOI: 10.1016/j.jns.2008.10.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  24 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  Autoimmune encephalopathy.

Authors:  Richard J Caselli; Joseph F Drazkowski; Dean M Wingerchuk
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

3.  A NORSE With No Name.

Authors:  David Spencer
Journal:  Epilepsy Curr       Date:  2016 Sep-Oct       Impact factor: 7.500

4.  New-onset refractory status epilepticus: Etiology, clinical features, and outcome.

Authors:  Nicolas Gaspard; Brandon P Foreman; Vincent Alvarez; Christian Cabrera Kang; John C Probasco; Amy C Jongeling; Emma Meyers; Alyssa Espinera; Kevin F Haas; Sarah E Schmitt; Elizabeth E Gerard; Teneille Gofton; Peter W Kaplan; Jong W Lee; Benjamin Legros; Jerzy P Szaflarski; Brandon M Westover; Suzette M LaRoche; Lawrence J Hirsch
Journal:  Neurology       Date:  2015-08-21       Impact factor: 9.910

Review 5.  Treatment of Super-Refractory Status Epilepticus.

Authors:  Ahmad Bayrlee; Nimalya Ganeshalingam; Lisa Kurczewski; Gretchen M Brophy
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

6.  New onset refractory status epilepticus (NORSE) as the heralding manifestation of herpes simplex encephalitis.

Authors:  Rajesh Verma; Tushar Premraj Raut; Prithvi Giri; Heramba Narayan Praharaj
Journal:  BMJ Case Rep       Date:  2013-07-25

Review 7.  Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis.

Authors:  Marianna Spatola; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2017-06       Impact factor: 5.710

8.  Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.

Authors:  Nicolas Gaspard; Brandon Foreman; Lilith M Judd; James N Brenton; Barnett R Nathan; Blathnaid M McCoy; Ali Al-Otaibi; Ronan Kilbride; Ivan Sánchez Fernández; Lucy Mendoza; Sophie Samuel; Asma Zakaria; Giridhar P Kalamangalam; Benjamin Legros; Jerzy P Szaflarski; Tobias Loddenkemper; Cecil D Hahn; Howard P Goodkin; Jan Claassen; Lawrence J Hirsch; Suzette M Laroche
Journal:  Epilepsia       Date:  2013-06-12       Impact factor: 5.864

9.  Claustrum damage and refractory status epilepticus following febrile illness.

Authors:  Stefano Meletti; Jana Slonkova; Iva Mareckova; Giulia Monti; Nicola Specchio; Petr Hon; Giada Giovannini; Vaclav Marcian; Annalisa Chiari; Petr Krupa; Nicola Pietrafusa; Dagmar Berankova; Michal Bar
Journal:  Neurology       Date:  2015-09-04       Impact factor: 9.910

10.  New-onset super-refractory status epilepticus: A case series of 26 patients.

Authors:  Elizabeth Matthews; Ayham Alkhachroum; Nina Massad; Riva Letchinger; Kevin Doyle; Jan Claassen; Kiran T Thakur
Journal:  Neurology       Date:  2020-09-17       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.